Search PubMed⌕ Search

PubMed · 8452743

Monitoring body temperature.

Abstract

Vigilant and accurate assessment of thermal balance is imperative with the critically ill. Disease, injury, or pharmacologic activity can impair thermoregulation, leaving patients vulnerable to uncontrolled gain or loss of heat. Body temperature provides cues to onset of infection, inflammation, and antigenic responses, as well as indicating efficacy of treatment. With knowledge of heat transfer principles, physiologic processes that distribute body heat, and principles of thermometry, the nurse is better equipped to make reasoned clinical judgment about this important vital sign. Choices of instruments or measurement sites are influenced by needs to estimate either hypothalamic temperature or shifts in body heat. Need for continuous versus episodic assessment, availability or intrusiveness of equipment, and stability of the patient also influence choices. Monitoring devices, measurement sites and techniques, equipment limitations and precautions are discussed. Interpretation and application of assessment findings are presented as they relate to abnormally high or low temperatures, patterns of fever, and temperature gradients.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

B J Holtzclaw. 1993. Monitoring body temperature.. https://pubmed.ncbi.nlm.nih.gov/8452743/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Combined steroid treatment for congenital heart surgery improves oxygen delivery and reduces postbypass inflammatory mediator expression.

BACKGROUND: Steroid administration during cardiopulmonary bypass is thought to improve cardiopulmonary function by modulating bypass-related inflammation. This study was designed to compare preoperative and intraoperative methylprednisolone (MP) to intraoperative MP alone with respect to postbypass inflammation and clinical outcome. METHODS AND RESULTS: Twenty-nine pediatric patients undergoing bypass procedures were randomly assigned to receive preoperative and intraoperative MP (30 mg/kg 4 hours before bypass and in bypass prime, n=14) or intraoperative MP only (30 mg/kg, n=15). Myocardial inflammatory mediator mRNA expression was determined in paired atrial biopsies (before and after bypass) by ribonuclease protection. Before and after bypass, serum IL-6 and IL-10 were measured by ELISA. Postoperative outcome was assessed by intubation time, CICU length of stay, fluid balance, arterio-venous O2 difference (DeltaA-VO2), and inotrope requirements. Compared with intraoperative MP alone, combined preoperative and intraoperative MP was associated with reduced myocardial mRNA expression for IL-6, MCP-1, and ICAM-1 both before and after bypass (P<0.05). Patients who received combined steroids had lower serum IL-6 and increased IL-10 at end-bypass (P<0.05), although differences were negligible by 24 hours. Combined MP treatment was associated with reduced fluid requirements, lower body temperature, and lower DeltaA-VO2 for the first 24 hours after surgery (P<0.05), along with trends toward improvement in other clinical outcomes. CONCLUSIONS: Compared with intraoperative steroid treatment, combined preoperative and intraoperative steroid administration attenuates inflammatory mediator expression more effectively and is associated with improved indexes of O2 delivery in the first 24 hours after congenital heart surgery. These findings need to be confirmed in a larger multicenter trial.

Body Temperature↗